Literature DB >> 23660844

Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A.

Belkis Romeu1, Miriam Lastre, Luis García, Bárbara Cedré, Aleida Mandariote, Mildrey Fariñas, Reynaldo Oliva, Einar Rosenqvist, Oliver Pérez.   

Abstract

Outer-membrane vesicles (OMVs) have inherent adjuvant properties, and many vaccines use OMV as vaccine components. Utilizing the adjuvant properties of OMV could lead to the formulation of vaccines that are less expensive and potentially more immunogenic than covalently conjugated polysaccharide vaccines. We evaluated the adjuvant effect in Balb/c mice of combinations of OMV from Neisseria meningitidis serogroup A and W135 as compared to that of the non-covalently conjugated capsular polysaccharide A. Both antigens were adsorbed onto aluminum hydroxide. The mice were given a booster dose of plain polysaccharide A to stimulate an immunologic memory response. Subclasses determination and cytokine assays demonstrated the capacity of OMV to induce a IgG2a/IgG2b isotype profile and IFN-γ production, suggesting the induction of a Th1 pattern immune response. Lymphoproliferative responses to OMVs were high, with affinity maturation of antibodies observed. Bactericidal titers after the booster dose were also observed. Memory B cells and long-term memory T cells were also detected. The results of this study indicate that combined meningococcal serogroup A and W135 OMV can activate cell-mediated immunity and induce a long-term memory response.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23660844     DOI: 10.1007/s12026-013-8427-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  40 in total

1.  IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants.

Authors:  D M Ambrosino; S K Sood; M C Lee; D Chen; H R Collard; D L Bolon; C Johnson; R S Daum
Journal:  Pediatr Infect Dis J       Date:  1992-10       Impact factor: 2.129

2.  Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.

Authors:  Judith Del Campo; Caridad Zayas; Belkis Romeu; Reinaldo Acevedo; Elizabeth González; Gustavo Bracho; Maribel Cuello; Osmir Cabrera; Julio Balboa; Miriam Lastre
Journal:  Methods       Date:  2009-05-04       Impact factor: 3.608

3.  Meningococcal serogroup C polysaccharide specific memory B cells, directly enumerated by labeled polysaccharide, are not affected by age at vaccination.

Authors:  Maren Henneken; Nicolas Burdin; Einar Thoroddsen; Sigurveig Th Sigurdardottir; Emanuelle Trannoy; Ingileif Jonsdottir
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

4.  Comparison of antibody kinetics following meningococcal serogroup C conjugate vaccine between healthy adults previously vaccinated with meningococcal A/C polysaccharide vaccine and vaccine-naïve controls.

Authors:  R Borrow; J Southern; N Andrews; N Peake; R Rahim; M Acuna; S Martin; E Miller; E Kaczmarski
Journal:  Vaccine       Date:  2001-04-30       Impact factor: 3.641

5.  Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine.

Authors:  O Pérez; M Lastre; J Lapinet; G Bracho; M Díaz; C Zayas; C Taboada; G Sierra
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern.

Authors:  Oliver Pérez; Gustavo Bracho; Miriam Lastre; Nestor Mora; Judith del Campo; Danay Gil; Caridad Zayas; Reinaldo Acevedo; Domingo González; José A López; Carlos Taboada; Cameron Turtle; Rosa L Solis
Journal:  Immunol Cell Biol       Date:  2004-12       Impact factor: 5.126

Review 7.  How bacterial carbohydrates influence the adaptive immune system.

Authors:  Fikri Y Avci; Dennis L Kasper
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

8.  Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

Authors:  Andrew J Pollard; Kirsten P Perrett; Peter C Beverley
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

9.  Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.

Authors:  A M Carcaboso; R M Hernández; M Igartua; J E Rosas; M E Patarroyo; J L Pedraz
Journal:  Vaccine       Date:  2004-03-29       Impact factor: 3.641

10.  Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.

Authors:  G V Sierra; H C Campa; N M Varcacel; I L Garcia; P L Izquierdo; P F Sotolongo; G V Casanueva; C O Rico; C R Rodriguez; M H Terry
Journal:  NIPH Ann       Date:  1991-12
View more
  5 in total

1.  Pathogenesis Mediated by Bacterial Membrane Vesicles.

Authors:  William J Gilmore; Natalie J Bitto; Maria Kaparakis-Liaskos
Journal:  Subcell Biochem       Date:  2021

Review 2.  The Therapeutic Benefit of Bacterial Membrane Vesicles.

Authors:  Natalie J Bitto; Maria Kaparakis-Liaskos
Journal:  Int J Mol Sci       Date:  2017-06-16       Impact factor: 5.923

Review 3.  Adjuvants are Key Factors for the Development of Future Vaccines: Lessons from the Finlay Adjuvant Platform.

Authors:  Oliver Pérez; Belkis Romeu; Osmir Cabrera; Elizabeth González; Alexander Batista-Duharte; Alexis Labrada; Rocmira Pérez; Laura M Reyes; Wendy Ramírez; Sergio Sifontes; Nelson Fernández; Miriam Lastre
Journal:  Front Immunol       Date:  2013-12-02       Impact factor: 7.561

4.  Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection.

Authors:  Majela González-Miró; Laura M Rodríguez-Noda; Mildrey Fariñas-Medina; Barbara Cedré-Marrero; Sandra Madariaga-Zarza; Caridad Zayas-Vignier; Mabel Hernández-Cedeño; Torsten Kleffmann; Dagmar García-Rivera; Vicente Vérez-Bencomo; Bernd H A Rehm
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

Review 5.  Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants.

Authors:  Kuang Tan; Ruizhen Li; Xiaotian Huang; Qiong Liu
Journal:  Front Microbiol       Date:  2018-04-26       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.